
Lorraine Spector
Examiner (ID: 17600, Phone: (571)272-0893 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1647, STIC, 1646, 1812 |
| Total Applications | 788 |
| Issued Applications | 338 |
| Pending Applications | 71 |
| Abandoned Applications | 379 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 663663
[patent_doc_number] => 07101981
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-09-05
[patent_title] => 'Bovine growth hormone recombinantly produced in E. coli '
[patent_app_type] => utility
[patent_app_number] => 08/487312
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5020
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/101/07101981.pdf
[firstpage_image] =>[orig_patent_app_number] => 08487312
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/487312 | Bovine growth hormone recombinantly produced in E. coli | Jun 6, 1995 | Issued |
Array
(
[id] => 266931
[patent_doc_number] => 07566455
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-07-28
[patent_title] => 'E6AP-binding proteins'
[patent_app_type] => utility
[patent_app_number] => 08/484878
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 30594
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/566/07566455.pdf
[firstpage_image] =>[orig_patent_app_number] => 08484878
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/484878 | E6AP-binding proteins | Jun 6, 1995 | Issued |
Array
(
[id] => 3929546
[patent_doc_number] => 05877285
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-02
[patent_title] => 'Mammalian thymokine having leukocyte chemotactic activity, and fragments thereof'
[patent_app_type] => 1
[patent_app_number] => 8/472604
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 25392
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/877/05877285.pdf
[firstpage_image] =>[orig_patent_app_number] => 472604
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/472604 | Mammalian thymokine having leukocyte chemotactic activity, and fragments thereof | Jun 6, 1995 | Issued |
Array
(
[id] => 3935070
[patent_doc_number] => 05989537
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-23
[patent_title] => 'Methods for stimulating granulocyte/macrophage lineage using thrombopoietin'
[patent_app_type] => 1
[patent_app_number] => 8/484257
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 27093
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/989/05989537.pdf
[firstpage_image] =>[orig_patent_app_number] => 484257
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/484257 | Methods for stimulating granulocyte/macrophage lineage using thrombopoietin | Jun 6, 1995 | Issued |
Array
(
[id] => 303728
[patent_doc_number] => 07534867
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-05-19
[patent_title] => 'Purified mammalian Flt3 ligands; agonists; antagonists'
[patent_app_type] => utility
[patent_app_number] => 08/484882
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 25946
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/534/07534867.pdf
[firstpage_image] =>[orig_patent_app_number] => 08484882
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/484882 | Purified mammalian Flt3 ligands; agonists; antagonists | Jun 6, 1995 | Issued |
Array
(
[id] => 299733
[patent_doc_number] => 07537932
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-05-26
[patent_title] => 'Antibodies that bind purified mammalian FLT3 ligands'
[patent_app_type] => utility
[patent_app_number] => 08/472168
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 25877
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/537/07537932.pdf
[firstpage_image] =>[orig_patent_app_number] => 08472168
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/472168 | Antibodies that bind purified mammalian FLT3 ligands | Jun 6, 1995 | Issued |
Array
(
[id] => 1125510
[patent_doc_number] => 06790439
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-09-14
[patent_title] => 'Thrombopoietin compositions'
[patent_app_type] => B1
[patent_app_number] => 08/486451
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4405
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/790/06790439.pdf
[firstpage_image] =>[orig_patent_app_number] => 08486451
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/486451 | Thrombopoietin compositions | Jun 6, 1995 | Issued |
Array
(
[id] => 1053082
[patent_doc_number] => 06858409
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-02-22
[patent_title] => 'Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 08/482283
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 24
[patent_no_of_words] => 18537
[patent_no_of_claims] => 105
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 237
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/858/06858409.pdf
[firstpage_image] =>[orig_patent_app_number] => 08482283
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/482283 | Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors | Jun 6, 1995 | Issued |
Array
(
[id] => 4404577
[patent_doc_number] => 06309640
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-30
[patent_title] => 'Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)'
[patent_app_type] => 1
[patent_app_number] => 8/472753
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 17
[patent_no_of_words] => 14270
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/309/06309640.pdf
[firstpage_image] =>[orig_patent_app_number] => 472753
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/472753 | Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay) | Jun 6, 1995 | Issued |
Array
(
[id] => 4265215
[patent_doc_number] => 06245329
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-12
[patent_title] => 'Method of inducing calcium flux in cells using mammalian thymokine protein'
[patent_app_type] => 1
[patent_app_number] => 8/477537
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 26157
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/245/06245329.pdf
[firstpage_image] =>[orig_patent_app_number] => 477537
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/477537 | Method of inducing calcium flux in cells using mammalian thymokine protein | Jun 6, 1995 | Issued |
| 08/475049 | RECOMBINANT MATERIALS FOR PRODUCTION OF SINGLE-CHAIN GLYCOPROTEIN HORMONES | Jun 6, 1995 | Abandoned |
Array
(
[id] => 1009122
[patent_doc_number] => 06899882
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-05-31
[patent_title] => 'Endothelial cell growth factor methods of isolation and expression'
[patent_app_type] => utility
[patent_app_number] => 08/473276
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 27
[patent_no_of_words] => 16063
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/899/06899882.pdf
[firstpage_image] =>[orig_patent_app_number] => 08473276
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/473276 | Endothelial cell growth factor methods of isolation and expression | Jun 5, 1995 | Issued |
Array
(
[id] => 3893608
[patent_doc_number] => 05750371
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-12
[patent_title] => 'Water-soluble mutein of FGF receptor, DNA and production thereof'
[patent_app_type] => 1
[patent_app_number] => 8/471570
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 11020
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/750/05750371.pdf
[firstpage_image] =>[orig_patent_app_number] => 471570
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/471570 | Water-soluble mutein of FGF receptor, DNA and production thereof | Jun 5, 1995 | Issued |
Array
(
[id] => 1327662
[patent_doc_number] => 06599873
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-29
[patent_title] => 'Interleukin-1 inhibitors, compositions, and methods of treatment'
[patent_app_type] => B1
[patent_app_number] => 08/468425
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 26
[patent_no_of_words] => 15241
[patent_no_of_claims] => 296
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/599/06599873.pdf
[firstpage_image] =>[orig_patent_app_number] => 08468425
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/468425 | Interleukin-1 inhibitors, compositions, and methods of treatment | Jun 5, 1995 | Issued |
Array
(
[id] => 3936233
[patent_doc_number] => 05981265
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-09
[patent_title] => 'Methods for regulating MEKK protein activity'
[patent_app_type] => 1
[patent_app_number] => 8/461146
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 40
[patent_no_of_words] => 46445
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/981/05981265.pdf
[firstpage_image] =>[orig_patent_app_number] => 461146
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/461146 | Methods for regulating MEKK protein activity | Jun 4, 1995 | Issued |
| 08/463222 | PRODUCTION OF HUMAN PARATHYROID HORMONE FROM MICROORGANISMS | Jun 4, 1995 | Abandoned |
Array
(
[id] => 4129596
[patent_doc_number] => 06146852
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-14
[patent_title] => 'Production of human parathyroid hormone from microorganisms'
[patent_app_type] => 1
[patent_app_number] => 8/461436
[patent_app_country] => US
[patent_app_date] => 1995-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 24
[patent_no_of_words] => 13369
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/146/06146852.pdf
[firstpage_image] =>[orig_patent_app_number] => 461436
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/461436 | Production of human parathyroid hormone from microorganisms | Jun 4, 1995 | Issued |
Array
(
[id] => 3811108
[patent_doc_number] => 05770209
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-23
[patent_title] => 'Acceleration of wound healing using connective tissue growth factor'
[patent_app_type] => 1
[patent_app_number] => 8/459717
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 18
[patent_no_of_words] => 18629
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/770/05770209.pdf
[firstpage_image] =>[orig_patent_app_number] => 459717
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/459717 | Acceleration of wound healing using connective tissue growth factor | Jun 1, 1995 | Issued |
Array
(
[id] => 3730252
[patent_doc_number] => 05670625
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-23
[patent_title] => 'Elk ligand fusion proteins'
[patent_app_type] => 1
[patent_app_number] => 8/460741
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15746
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/670/05670625.pdf
[firstpage_image] =>[orig_patent_app_number] => 460741
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/460741 | Elk ligand fusion proteins | Jun 1, 1995 | Issued |
Array
(
[id] => 4045377
[patent_doc_number] => 05874539
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-23
[patent_title] => 'Antibodies to nuclear matrix proteins'
[patent_app_type] => 1
[patent_app_number] => 8/459023
[patent_app_country] => US
[patent_app_date] => 1995-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 14039
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 280
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/874/05874539.pdf
[firstpage_image] =>[orig_patent_app_number] => 459023
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/459023 | Antibodies to nuclear matrix proteins | Jun 1, 1995 | Issued |